20th Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2013, Atlanta
1 May 2013. Related: Conference reports.
CROI (Retrovirus) 20 Atlanta 2013
ARV pipeline: dolutegravir, TAF (GS-7340), MK-1439 and cenicriviroc
1 May 2013. Related: Conference reports, Antiretrovirals.
ARV pipeline: long-acting formulations of rilpivirine, GSK-744 and nanoformulations
1 May 2013. Related: Conference reports, Antiretrovirals.
Five-year results from the AntiRetroviral Research for Watoto (ARROW) Trial
1 May 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
Comparison of ritonavir-boosted lopinavir or NNRTI ART and PK with antimalarials in Ugandan children
1 May 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
Pharmacokinetics of currently available antiretroviral options for young children
1 May 2013. Related: Conference reports, Antiretrovirals, PK and drug interactions, Paediatric care.
Safety of transplacental raltegravir in neonates and washout pharmacokinetics
1 May 2013. Related: Conference reports, Antiretrovirals, PK and drug interactions, PMTCT and maternal health.
Tenofovir use in children
1 May 2013. Related: Conference reports, Antiretrovirals, Paediatric care.
ddI resistance in South African children failing an abacavir or d4T based first-line regimen
1 May 2013. Related: Conference reports, Antiretrovirals, Paediatric care, Resistance.
Statin use in HIV positive people
1 May 2013. Related: Conference reports, Side effects.
RIFAQUIN study demonstrates once-weekly dosing during follow-up phase of TB treatment
1 May 2013. Related: Conference reports, Opportunistic infections, TB coinfection.
Study indicates rifampicin dose should be higher
1 May 2013. Related: Conference reports, Antiretrovirals, TB coinfection.
Counter-intuitive result of IPT plus ART trial
1 May 2013. Related: Conference reports, Antiretrovirals, TB coinfection.
Combining Xpert and LAM urine testing improves TB diagnostic sensitivity
1 May 2013. Related: Conference reports, Opportunistic infections, TB coinfection.
Deferring ART by four weeks reduces mortality in patients diagnosed with cryptococcal meningitis
1 May 2013. Related: Conference reports, Opportunistic infections.
Monthly injection protects macaques from rectal exposure: results should fast-track human studies for advanced PrEP options
1 May 2013. Related: Conference reports, Prevention.
Tenofovir DF ring protects macaques from vaginal exposure
1 May 2013. Related: Conference reports, Transmission, Prevention.
VOICE study reports low adherence as reason for lack of efficacy for PrEP: anal sex common in African heterosexuals
1 May 2013. Related: Conference reports, Transmission, Prevention.
Further studies on how male circumcision may reduce HIV transmission
1 May 2013. Related: Conference reports, Transmission, Prevention.
Report of a functional cure in an HIV infected infant
1 May 2013. Related: Conference reports, Paediatric care, Cure research.
RIFAQUIN trial proves new TB regimen
22 April 2013. Related: Conference reports, TB coinfection.